Cargando…

Fulminant Myocarditis Managed by Extracorporeal Life Support (Impella® CP): A Rare Case

BACKGROUND: Treating myocarditis can be difficult, as clear criteria for diagnosis and management are lacking for heterogeneous clinical presentations. CASE DESCRIPTION: We report a case of a 49-year-old female who presented with cardiogenic shock and subsequent cardiac arrest. Extracorporeal life s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fox, Henrik, Farr, Martin, Horstkotte, Dieter, Flottmann, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5529618/ https://www.ncbi.nlm.nih.gov/pubmed/28785489 http://dx.doi.org/10.1155/2017/9231959

Ejemplares similares

COVID-19 fulminant myocarditis recovered with veno-arterial extracorporeal membrane oxygenation and Impella CP
por: Matsushita, Shunsuke, et al.
Publicado: (2023)

Fulminant myocarditis managed with pulsatile extracorporeal life support; use of Twin Pulse Life support (T-PLS(®))
por: Cho, Eun Jeung, et al.
Publicado: (2011)

Efficacy of central extracorporeal life support for patients with fulminant myocarditis and cardiogenic shock
por: Tadokoro, Naoki, et al.
Publicado: (2021)

Successful cases of percutaneous left ventricular assist device “Impella” to fulminant myocarditis
por: Hori, Takayuki, et al.
Publicado: (2022)

The Clinical Potential of Impella 5.0 Support in the Treatment of Recurrent Fulminant Viral Myocarditis with Profound Cardiogenic Shock
por: Ogawa, Shou, et al.
Publicado: (2019)

Mechanical Unloading by Fulminant Myocarditis: LV-IMPELLA, ECMELLA, BI-PELLA, and PROPELLA Concepts
por: Tschöpe, Carsten, et al.
Publicado: (2018)

Acute hypoxemia caused by Impella in a patient with fulminant myocarditis and patent foramen ovale
por: Shibao, Kodai, et al.
Publicado: (2022)

Successfully Treated Acute Fulminant Myocarditis Induced by Ulcerative Colitis with Extracorporeal Life Support and Infliximab
por: Kim, Han-Kyul, et al.
Publicado: (2016)

Case of Coronavirus Disease 2019 Myocarditis Managed With Biventricular Impella Support
por: Ruiz, Jose G, et al.
Publicado: (2021)

Enhanced recovery from fulminant myocarditis by treatment with the combined use of the Impella left ventricular assist device with extracorporeal membrane oxygenation: a case series
por: Nandate, Hideyuki, et al.
Publicado: (2022)

Concomitant use of veno-arterial extracorporeal membrane oxygenation and Impella in the intensive care unit: a case report of fulminant myocarditis with multi-organ failure
por: Gawda, Ryszard, et al.
Publicado: (2020)

Novel Combination of Impella and Extra Corporeal Membrane Oxygenation as a Bridge to Full Recovery in Fulminant Myocarditis
por: Narain, Sachin, et al.
Publicado: (2012)

Fulminant Myocarditis After SARS-CoV-2 mRNA Vaccine Successfully Managed With Biventricular Impella Support: Multimodality Imaging Follow-Up
por: Ching, Shing, et al.
Publicado: (2022)

Successful Treatment of Novel H1N1 Influenza related Fulminant Myocarditis with Extracorporeal Life Support
por: Mohite, Prashant Nanasaheb, et al.
Publicado: (2011)

The First Reported Case of COVID-19 Myocarditis Managed with Biventricular Impella Support
por: Ruiz, J., et al.
Publicado: (2021)

The use of extracorporeal membrane oxygenation in children with acute fulminant myocarditis
por: Heinsar, Silver, et al.
Publicado: (2020)

MANAGEMENT OF COVID-19 MYOPERICARDITIS WITH AN IMPELLA CP
por: Wen, Jason, et al.
Publicado: (2021)

Local Experience with Extracorporeal Membrane Oxygentaion in Children with Acute Fulminant Myocarditis
por: Ning, Botao, et al.
Publicado: (2013)

Fulminant myocarditis: use of echocardiography from diagnosis to extracorporeal membrane oxygenation
por: Park, Na Hyun, et al.
Publicado: (2020)

Nursing care for children with fulminant myocarditis treated with extracorporeal membrane oxygenation
por: Wang, Zaihua, et al.
Publicado: (2023)

Extracorporeal life support survival in a pediatric hematopoietic cellular transplant recipient with presumed GvHD-related fulminant myocarditis
por: Zinter, M S, et al.
Publicado: (2017)

Impella versus extracorporal life support in cardiogenic shock: a propensity score adjusted analysis
por: Wernly, Bernhard, et al.
Publicado: (2021)

Extracorporeal Cardiopulmonary Resuscitation for Management of Out-of-Hospital Cardiac Arrest in a Patient with Fulminant Myocarditis
por: Meyer, Alexander J., et al.
Publicado: (2020)

Prognosis of patients with fulminant myocarditis managed by peripheral venoarterial extracorporeal membranous oxygenation support: a retrospective single-center study
por: Nakamura, Tomohiro, et al.
Publicado: (2015)

Trends in Veno‐Arterial Extracorporeal Life Support With and Without an Impella or Intra‐Aortic Balloon Pump for Cardiogenic Shock
por: Hendrickson, Michael J., et al.
Publicado: (2022)

Impact of mechanical circulatory support and immunomodulation therapy on outcome of patients with fulminant myocarditis: Chinese registry of fulminant myocarditis
por: Zhou, Ning, et al.
Publicado: (2021)

Acute Fulminant Myocarditis Following Influenza Vaccination Requiring Extracorporeal Membrane Oxygenation
por: Kim, Youn-Jung, et al.
Publicado: (2019)

Left Ventricular Mechanical Support with the Impella during Extracorporeal Membrane Oxygenation
por: Moazzami, Kasra, et al.
Publicado: (2017)

Clinical determinants of successful weaning from extracorporeal membrane oxygenation in patients with fulminant myocarditis
por: Matsumoto, Manabu, et al.
Publicado: (2018)

Associations with the In-Hospital Survival Following Extracorporeal Membrane Oxygenation in Adult Acute Fulminant Myocarditis
por: Chong, Shaur-Zheng, et al.
Publicado: (2018)

Factors Associated With In-hospital Mortality of Children With Acute Fulminant Myocarditis on Extracorporeal Membrane Oxygenation
por: Lee, En-Pei, et al.
Publicado: (2020)

Coronavirus Associated Fulminant Myocarditis Successfully Treated With Intravenous Immunoglobulin and Extracorporeal Membrane Oxygenation
por: Rao, Sangeetha, et al.
Publicado: (2014)

Fulminant Myocarditis in a Child Requiring Extracorporeal Cardiopulmonary Resuscitation: A Case Report
por: Sayuri, Takehara, et al.
Publicado: (2022)

Cardiac recovery from COVID-19–associated fulminant myocarditis by extracorporeal biventricular assist
por: Takami, Yoshiyuki, et al.
Publicado: (2023)

Prognostic factors in children with acute fulminant myocarditis receiving venoarterial extracorporeal membrane oxygenation
por: Sun, Mingwei, et al.
Publicado: (2022)

Outcomes after extracorporeal life support for COVID-19 myocarditis: an analysis of the Extracorporeal Life Support Organization Registry
por: Tonna, Joseph E., et al.
Publicado: (2022)

Fulminant Eosinophilic Myocarditis: A Rare and Life-Threatening Presentation of Eosinophilic Granulomatosis With Polyangiitis
por: Lopes, Pedro M., et al.
Publicado: (2020)

Comparison of Mechanical Support with Impella or Extracorporeal Life Support in Post-Cardiac Arrest Cardiogenic Shock: A Propensity Scoring Matching Analysis
por: Syntila, Styliani, et al.
Publicado: (2021)

Early characteristics of fulminant myocarditis vs non-fulminant myocarditis: A meta-analysis
por: Wang, Zicheng, et al.
Publicado: (2019)

Mechanical Circulatory Support as a Bridge to Recovery in Fulminant Myocarditis
por: Iqbal, Yassir, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_eqi8h1qaa5sfco0kgt1uiage8k